Cannabis companies have been on a terrifying decline for the past six months. And we’re about to dive headlong into earnings season once again.

Investors looking for the safest bets need to start focusing on profits and operating income instead of revenue.

With a lot of consumer spending on the horizon, a trend and seasonal trader like me loves this time of year.

This week we’re looking at the companies at the leading edge of 5G development, ranked by the number of patents they hold.

Investors looking to capture the most growth in American marijuana markets need to have exposure on both coasts.

This week, we’re reminding investors that not ALL cannabis stocks are down. Here are the top performers from the past month.

We’re looking at marijuana stocks using one of the most conservative valuation metrics there is: price to tangible book value.

Outside of the major indexes, gains are still being made… especially in American pot stocks.

For now, Curaleaf is the cannabis company to beat in the U.S. But can it continue to outpace its competitors?

Unprecedented fluctuations in cannabis have led to a rise in short interest – and companies are feeling the heat.